Clinical Trials Logo

Childhood-onset Fluency Disorder clinical trials

View clinical trials related to Childhood-onset Fluency Disorder.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05583955 Completed - Clinical trials for Childhood-Onset Fluency Disorder

A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)

Start date: July 25, 2022
Phase: Phase 2
Study type: Interventional

This study is designed to evaluate the effectiveness of NOE-105 on speech fluency without the known antipsychotic-induced side effects of commonly used treatments for childhood onset fluency disorder (COFD).

NCT ID: NCT04492956 Completed - Clinical trials for Childhood-Onset Fluency Disorder (Stuttering)

Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)

Start date: October 2, 2020
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, Phase 2 exploratory study in adult subjects with childhood onset fluency disorder.